Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024
Palatin Technologies (NYSE American: PTN) has announced it will release its first quarter fiscal year 2025 financial results on November 14, 2024, before U.S. markets open. The company will host a conference call and webcast at 11:00 a.m. ET the same day, featuring executive management's review of operating results and development program updates. The earnings release is scheduled for 7:30 a.m. ET, with a conference call replay available until November 28, 2024. Palatin is a biopharmaceutical company focused on developing first-in-class medicines based on melanocortin receptor systems.
Palatin Technologies (NYSE American: PTN) ha annunciato che pubblicherà i risultati finanziari del primo trimestre dell'anno fiscale 2025 il 14 novembre 2024, prima dell'apertura dei mercati statunitensi. L'azienda ospiterà una conferenza telefonica e una trasmissione in diretta web alle 11:00 ET dello stesso giorno, durante la quale la direzione esecutiva presenterà una rassegna dei risultati operativi e aggiornamenti sui programmi di sviluppo. La pubblicazione degli utili è prevista per le 7:30 ET, con una registrazione della conferenza telefonica disponibile fino al 28 novembre 2024. Palatin è un'azienda biofarmaceutica concentrata nello sviluppo di medicinali di prima classe basati sui sistemi del recettore melanocortinico.
Palatin Technologies (NYSE American: PTN) ha anunciado que publicará sus resultados financieros del primer trimestre del año fiscal 2025 el 14 de noviembre de 2024, antes de la apertura de los mercados en EE. UU. La empresa realizará una conferencia telefónica y una transmisión web a las 11:00 a.m. ET el mismo día, en la que la dirección ejecutiva revisará los resultados operativos y proporcionará actualizaciones sobre los programas de desarrollo. La publicación de ganancias está programada para las 7:30 a.m. ET, con una repetición de la conferencia telefónica disponible hasta el 28 de noviembre de 2024. Palatin es una empresa biofarmacéutica centrada en el desarrollo de medicamentos de primera clase basados en sistemas de receptores melanocortina.
Palatin Technologies (NYSE American: PTN)는 2025 회계 연도 첫 분기 재무 결과를 2024년 11월 14일에 발표할 것이라고 밝혔습니다. 이는 미국 시장이 열리기 전에 이루어집니다. 이날 오전 11:00 ET에 경영진이 운영 결과와 개발 프로그램 업데이트를 평가하는 전화 회의 및 웹캐스트를 개최할 예정입니다. 수익 발표는 오전 7:30 ET에 예정되어 있으며, 전화 회의 녹음은 2024년 11월 28일까지 이용 가능합니다. Palatin은 멜라노코르틴 수용체 시스템을 기반으로 1세대 의약품을 개발하는 데 집중하는 생명공학 회사입니다.
Palatin Technologies (NYSE American: PTN) a annoncé qu'il publiera ses résultats financiers du premier trimestre de l'exercice fiscal 2025 le 14 novembre 2024, avant l'ouverture des marchés américains. L'entreprise organisera un appel conférence et un webinaire le même jour à 11h00 ET, où la direction exécutive présentera un bilan des résultats opérationnels et des mises à jour sur les programmes de développement. La publication des résultats est prévue pour 7h30 ET, avec une rediffusion de l'appel conférence disponible jusqu'au 28 novembre 2024. Palatin est une entreprise biopharmaceutique axée sur le développement de médicaments de première classe basés sur des systèmes de récepteurs melanocortiniques.
Palatin Technologies (NYSE American: PTN) hat angekündigt, dass die Finanzzahlen für das erste Quartal des Geschäftsjahres 2025 am 14. November 2024 veröffentlicht werden, bevor die US-Märkte öffnen. Das Unternehmen wird am selben Tag um 11:00 Uhr ET eine Telefonkonferenz und ein Webcast veranstalten, in dem das Management die Betriebsergebnisse und Updates zu den Entwicklungsprogrammen vorstellen wird. Die Veröffentlichung der Ergebnisse ist für 7:30 Uhr ET geplant, und die Aufnahme der Telefonkonferenz wird bis zum 28. November 2024 verfügbar sein. Palatin ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Medikamenten der ersten Klasse auf Grundlage von Melanocortin-Rezeptorsystemen konzentriert.
- None.
- None.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2024, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q1 Fiscal Year 2025 Results Press Release | 11/14/2024 at 7:30 a.m. ET |
Q1 Fiscal Year 2025 Conference Call-Live | 11/14/2024 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code: | 176159 |
Q1 Fiscal Year 2025 Conference Call-Replay | 11/14/2024-11/28/2024 |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 51641 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-first-quarter-fiscal-year-2025-results-teleconference-and-webcast-to-be-held-on-november-14-2024-302300035.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies (PTN) report Q1 2025 earnings?
How can I access Palatin Technologies' (PTN) Q1 2025 earnings call?
How long will Palatin Technologies' (PTN) Q1 2025 earnings call replay be available?
